Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patients

BMC Cardiovascular Disorders (2024) - Comments
doi: 10.1186/s12872-024-04376-y pubmed: 39702045 issn: 1471-2261

Sabine Hazan, Adriana C. Vidal, Nicolas Hulscher, Amelia Goudzwaard, Peter A. McCullough, Alon A. Steinberg